江蘇淮安新立誠(chéng)化工有限公司
江蘇淮安新立誠(chéng)化工有限公司
Main Products:Losartan Potassium, Hydrochlorothiazide, Rosiglitazone Maleate,
View moreAbout Us
Contact Supplier
Hot Products
+ more
Losartan Potassium
Health & Medical/Pharmaceuticals & Raw Materials/Chemical APIsNegotiable
Send Inquiry
Hydrochlorothiazide
Health & Medical/Pharmaceuticals & Raw Materials/Chemical APIsNegotiable
Send Inquiry
Rosiglitazone Maleate
Health & Medical/Pharmaceuticals & Raw Materials/Chemical APIsNegotiable
Send Inquiry
5-[4-[2-[N-Methyl-N- (pyridinyl) amino]ethoxy]benzyl]thiazolidine-2,4-dione hydrochloride
Chemicals/Intermediates/Pesticide IntermediatesNegotiable
Send Inquiry
Pioglitazone Hydrochloride
Health & Medical/Pharmaceuticals & Raw Materials/Chemical APIsNegotiable
Send InquiryCompany Profile
+ more
was established in 2007 in Chuzhou District, Huai'an City, Jiangsu Province. It is a high-tech production enterprise in the pharmaceutical and chemical field, dedicated to the development, production, and sales of pharmaceutical intermediates and active ingredients. The company primarily manufactures pharmaceutical raw materials and chemical intermediates. In addition to domestic sales, its products are exported to multiple countries and regions, including South Korea, Italy, Spain, and India. The company also provides comprehensive technical services for pharmaceutical intermediates and active ingredients to domestic and international clients. Furthermore, it has established cooperative relationships with domestic research institutes to continuously enhance the quantity, speed, and quality of the development and production transformation of active pharmaceutical ingredients and fine chemicals. In 2010, Beijing Synniken Times Technology Co., Ltd. was established in Beijing to engage in the operation and import-export of chemical raw materials and intermediates.
We consistently adhere to the corporate culture philosophy of "Integrity and Pragmatism, Customer First, Striving for Progress, and Mutual Development." In the pharmaceutical and chemical sector, we engage in long-term, multi-channel, and extensive cooperative relationships with peers, continuously explore new markets, increase investment in research and development, and expand production scale. This has enabled the company to adopt a specialized and large-scale operational model, entering a phase of healthy and rapid development.
